Bio Farma to Release 122.5 Million Vaccine Doses by September 2021

Consumer Services & Health

Lite

Yosepha Pusparisa 16/04/2021 14:00 WIB

URL has been copied

Memuat...

Bio Farma (Persero) has released its Sinovac-based Covid-19 vaccine since February 2021. The state-owned enterprise plans to release 122.5 million doses of the corona vaccine by September 2021.

Bio Farma's Product Release Plan for Vaccines (2021)

A Font Kecil
A Font Sedang
A Font Besar

Access single data

Bio Farma to Release 122.5 Million Vaccine Doses by September 2021

Want to get more access to Data Stories with a more affordable price? Subscribe.

By subscribing, you join us in presenting quality data.

Get:

Premium Data Stories access
Comfortable reading without ads
Download data in XLS, PDF, and image format
Access to data source information

Basic

~~Rp100.000~~

Rp50.000/month

Professional

~~Rp100.000~~

Rp150.000/month

Institutional For organizations

We accept the following payments:

Some payment methods are still in the process of being activated.

Bio Farma's Product Release Plan for Vaccines (2021)

Download

Source

A Small Font
A Medium Font
A Bigger Font

PT Bio Farma (Persero) released its Sinovac-based COVID-19 vaccine in February 2021. The state-owned enterprise planned to release 122.5 million doses by September 2021.

The largest vaccine releases were scheduled for July and August 2021, with 25.2 million doses distributed each month.

Bio Farma planned to add another 3 million doses of the finished CoronaVac vaccine. Furthermore, the company was in the process of obtaining additional Sinovac bulk ingredients. As a result, the total number of vaccines Bio Farma would produce would exceed 225 million doses by the first quarter of 2022.

Editor : Dimas Jarot Bayu

"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."